Skip to main content
The BMJ logoLink to The BMJ
letter
. 1991 Jun 22;302(6791):1536–1537.

Estimating risk of Down's syndrome

K Spencer, P Carpenter
PMCID: PMC1670165

Full text

PDF
1536

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Holding S. Biochemical screening for Down's syndrome. BMJ. 1991 May 25;302(6787):1275–1275. doi: 10.1136/bmj.302.6787.1275-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Macri J. N., Kasturi R. V., Krantz D. A., Cook E. J., Moore N. D., Young J. A., Romero K., Larsen J. W., Jr Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin. Am J Obstet Gynecol. 1990 Oct;163(4 Pt 1):1248–1253. doi: 10.1016/0002-9378(90)90700-h. [DOI] [PubMed] [Google Scholar]
  3. Reynolds T. M. Software for screening to assess risk of Down's syndrome. BMJ. 1991 Apr 20;302(6782):965–965. doi: 10.1136/bmj.302.6782.965. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES